CRISPR Therapeutics AG (CRSP)

53.46 -1.18 (-2.16%) USD  |  NASDAQ  |  Feb 20, 16:00
52.83 -0.63 (-1.18%) After-Hours: 06:03
More

CRISPR Therapeutics Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Novartis AG Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
EvoNext Holdings SA --